Get the Stockscreener App
0.5879
2.73%
-0.0165
After Hours:
.56
-0.0279
-4.75%
Mainz Biomed N V stock is traded at $0.5879, with a volume of 213.67K.
It is down -2.73% in the last 24 hours and up +0.00% over the past month.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
See More
Previous Close:
$0.6044
Open:
$0.6
24h Volume:
213.67K
Relative Volume:
2.66
Market Cap:
$7.36M
Revenue:
$895.50K
Net Income/Loss:
$-26.30M
P/E Ratio:
-0.00897
EPS:
-65.5728
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.5502
$0.60
1-Week Range:
$0.5501
$0.7977
52-Week Range:
$0.5501
$0.7977
Mainz Biomed N V Stock (QUCY) Company Profile
Name
Mainz Biomed N V
Sector
Industry
Phone
-
Address
-
Compare QUCY vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QUCY
Mainz Biomed N V
|
0.5879 | 7.56M | 895.50K | -26.30M | 0 | -65.57 |
|
TMO
Thermo Fisher Scientific Inc
|
470.21 | 172.63B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
190.11 | 135.42B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
579.85 | 45.95B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.75 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
299.57 | 28.94B | 3.17B | 642.63M | 516.49M | 10.77 |
Mainz Biomed N V Stock (QUCY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Initiated | Maxim Group | Buy |
| Nov-25-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-21-23 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-21-22 | Initiated | H.C. Wainwright | Buy |
Mainz Biomed N V Stock (QUCY) Latest News
Mainz Biomed (QUCY) Stock Chart and Price History 2026 - MarketBeat
Mainz Biomed (QUCY) Stock Forecast and Price Target 2026 - MarketBeat
Total cash dividends paid of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Published on: 2026-03-19 07:11:22 - baoquankhu1.vn
What is the current Price Target and Forecast for Mainz Biomed NV (QUCY) - Zacks Investment Research
Mainz Biomed N.V. Earnings and Revenue – NASDAQ:QUCY - TradingView
QUCY: Mainz Biomed NVPrice & Consenus Chart - Zacks Investment Research
Mainz Biomed (QUCY) Stock Trends and Sentiment 2026 - MarketBeat
Mainz Biomed receives $3M tranche from shareholder Lazar By Investing.com - Investing.com South Africa
Mainz Biomed changes ticker symbol to QUCY - MSN
Mainz Biomed receives $3M tranche from shareholder Lazar - Investing.com
Quantum Cyber (NASDAQ: QUCY) backed by $6M pre-funded Lazar funding - Stock Titan
QUCY Technical Analysis & Stock Price Forecast - Intellectia AI
QUCY Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Mainz Biomed (QUCY) Stock Price, News & Analysis - MarketBeat
Mainz Biomed (QUCY) Stock Analysis Report | Financials & Insights - Benzinga
symbol__ Stock Quote Price and Forecast - CNN
QUCY : Mainz Biomed Nv Key Company Details - Zacks Investment Research
Diluted net income available to common stockholders of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Operating expenses (excl. COGS) of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Diluted earnings per share (diluted EPS) of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Gross profit of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Mainz Biomed NV (QUCY) - Zacks Investment Research
Free cash flow of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
After tax other income/expense of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Net debt of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Total revenue of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Non-controlling/minority interest of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Non-operating income (total) of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Mainz Biomed NV (QUCY) Return On Assets (TTM) - Zacks Investment Research
Mainz Biomed NV (QUCY) Dividend Yield (TTM) - Zacks Investment Research
Price to cash flow ratio of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Mainz Biomed N.V. Cash Flow – NASDAQ:QUCY - TradingView
Total liabilities of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Diluted shares outstanding of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Mainz Biomed N.V. Balance Sheet – NASDAQ:QUCY - TradingView
Pretax income of Mainz Biomed N.V. – BOATS:QUCY - TradingView
Equity in earnings of Mainz Biomed N.V. – BOATS:QUCY - TradingView
Operating cash flow per share of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Inventory turnover of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Debt to equity ratio of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
CapEx per share of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Free cash flow per share of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
EBITDA margin % of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
EBITDA per share of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Gross margin % of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Price to book ratio of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Debt to assets ratio of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Tangible book value per share of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Working capital per share of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Return on equity % of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Mainz Biomed N V Stock (QUCY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
2.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):